Product Information
MEROPENEM IV 1 GM VIAL is a generic product labeled by Armas Pharmaceuticals Inc., priced at $5.1627 per EA under NDC 72485041210. Its NADAC has been published 115 times since Apr 17, 2024.
The High Outlier badge above means this manufacturer's average price in the Meropenem market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 g/20mL
Manufacturer
Armas Pharmaceuticals Inc.NDC
72485041210
Classification
Generic
Dosage Form
INJECTION
Route
INTRAVENOUS
Last Updated
6/17/2026
Active Ingredients
MEROPENEMApproval Type
Generic (ANDA)
FDA Application
ANDA216154On Market Since
5/31/2023
Pharmacological Classes
Price Statistics
The NADAC for MEROPENEM IV 1 GM VIAL has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 11.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.1627 per EA |
|---|---|
| All-time high | $7.6153 (Nov 13, 2024) |
| All-time low | $5.1627 (Jun 17, 2026) |
| 52-week high | $5.8381 |
| 52-week low | $5.1627 |
| Median price | $5.7092 |
| Average price | $5.9090 |
| Largest weekly change | +15.4% (Oct 23, 2024) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MEROPENEM IV 1 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for MEROPENEM IV 1 GM VIAL, manufactured by Armas Pharmaceuticals Inc., is $5.1627 per EA (NDC 72485041210), effective Jun 24, 2026.
How has the price of MEROPENEM IV 1 GM VIAL changed over time?
Over the history we have for it, the NADAC for MEROPENEM IV 1 GM VIAL has declined 11.4%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for MEROPENEM IV 1 GM VIAL?
Since Apr 17, 2024, the NADAC for MEROPENEM IV 1 GM VIAL has ranged from a low of $5.1627 (Jun 17, 2026) to a high of $7.6153 (Nov 13, 2024), with a median of $5.7092 per EA.
Are there cheaper alternatives to MEROPENEM IV 1 GM VIAL?
6 NADAC-published products share the same active ingredient, strength, and dosage form as MEROPENEM IV 1 GM VIAL, but none are currently priced below it.
Who manufactures MEROPENEM IV 1 GM VIAL?
MEROPENEM IV 1 GM VIAL (NDC 72485041210) is labeled by Armas Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification